BACKGROUND: The administration of injections has become an increasingly common addition to pharmacists' scope of practice. Four Canadian provinces, all US states and a number of other countries have regulations allowing pharmacists to administer injections. However, the extent to which such services are remunerated is unknown. METHODS: We contacted regulatory and advocacy organizations within those jurisdictions where pharmacists are authorized to administer injections to identify publicly funded programs that pay pharmacists for these services, as well as details of the eligible drugs/vaccines. Patient or private insurer payment programs were excluded. RESULTS: Of the 281 organizations we contact-ed, 104 provided information on a total of 34 pharmacist vaccination programs throughout Canada, the United States, England, Wales and Ireland. Converted to 2013 Canadian dollars, remuneration averages $13.12 (SD $4.63) per injection (range, $4.14-$21.21). All regions allow pharmacists to bill for administration of the influenza vaccine, while some states allow for a number of other vaccines. Alberta has the broadest range of injections eligible for remuneration. DISCUSSION: Despite evidence of increased vaccination rates in areas allowing pharmacist administration of injections, the availability of publicly funded remuneration programs and the fee offered vary by more than 5-fold across North America and the United Kingdom. CONCLUSION: Pharmacist-administered injections have great public health potential. The range of injections eligible for remuneration should be expanded to include a wide range of vaccines and other injectable drugs, and remuneration should be sufficient to encourage more pharmacists to provide this service.
BACKGROUND: The administration of injections has become an increasingly common addition to pharmacists' scope of practice. Four Canadian provinces, all US states and a number of other countries have regulations allowing pharmacists to administer injections. However, the extent to which such services are remunerated is unknown. METHODS: We contacted regulatory and advocacy organizations within those jurisdictions where pharmacists are authorized to administer injections to identify publicly funded programs that pay pharmacists for these services, as well as details of the eligible drugs/vaccines. Patient or private insurer payment programs were excluded. RESULTS: Of the 281 organizations we contact-ed, 104 provided information on a total of 34 pharmacist vaccination programs throughout Canada, the United States, England, Wales and Ireland. Converted to 2013 Canadian dollars, remuneration averages $13.12 (SD $4.63) per injection (range, $4.14-$21.21). All regions allow pharmacists to bill for administration of the influenza vaccine, while some states allow for a number of other vaccines. Alberta has the broadest range of injections eligible for remuneration. DISCUSSION: Despite evidence of increased vaccination rates in areas allowing pharmacist administration of injections, the availability of publicly funded remuneration programs and the fee offered vary by more than 5-fold across North America and the United Kingdom. CONCLUSION: Pharmacist-administered injections have great public health potential. The range of injections eligible for remuneration should be expanded to include a wide range of vaccines and other injectable drugs, and remuneration should be sufficient to encourage more pharmacists to provide this service.
Authors: Darren Lau; Jia Hu; Sumit R Majumdar; Dale A Storie; Sandra E Rees; Jeffrey A Johnson Journal: Ann Fam Med Date: 2012 Nov-Dec Impact factor: 5.166
Authors: Jennifer E Isenor; Melissa S Kervin; Donna M Halperin; Joanne Langley; Julie A Bettinger; Karina A Top; Fawziah Lalji; Kathryn Slayter; Janusz Kaczorowski; Susan K Bowles; Nancy M Waite; Scott A Halperin Journal: Can Pharm J (Ott) Date: 2020-02-17
Authors: Sherilyn K D Houle; Theresa L Charrois; Finlay A McAlister; Michael R Kolber; Meagen M Rosenthal; Richard Lewanczuk; Norman R C Campbell; Ross T Tsuyuki Journal: Can Pharm J (Ott) Date: 2016-10-03
Authors: A M Di Castri; D M Halperin; L Ye; D MacKinnon-Cameron; M Kervin; J E Isenor; S A Halperin Journal: Hum Vaccin Immunother Date: 2021-05-14 Impact factor: 3.452